YPrime Acquires Tryl

Article

YPrime, LLC has announced the acquisition of Tryl, a software development company with a patient engagement solution that brings together design, personalization, and applied behavioral science that is designed to boost engagement, reduce dropouts, and deliver outcomes in clinical trials. The acquisition includes the transfer of all staff, development capabilities, and intellectual properties to YPrime, and will integrate with YPrime's Patient Engagement Technologies solutions.

Read more about the acquisition here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.